Stay updated on A4250 in Children With PFIC Clinical Trial
Sign up to get notified when there's something new on the A4250 in Children With PFIC Clinical Trial page.

Latest updates to the A4250 in Children With PFIC Clinical Trial page
- ChecktodayChange DetectedA site-wide banner announces NIH updates about transitioning terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check7 days agoChange DetectedThe site footer’s revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check35 days agoChange Detected- A 403 Forbidden page is added/updated, including a basic HTML header, the message '403 Forbidden', a Home link, and a revision label (Revision: v3.7.0), reflecting the access-restricted state of the page.SummaryDifference19%

- Check49 days agoChange DetectedOpen-label extension study details for A4250 in PFIC were added, outlining long-term safety, dosing, and multiple outcomes across many sites; the previous extension description was removed.SummaryDifference3%

- Check56 days agoChange DetectedThe page now shows an NIH grant/contract funding note for 2017, and the site revision tag was updated to v3.6.6 (from v3.6.5).SummaryDifference0.1%

Stay in the know with updates to A4250 in Children With PFIC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the A4250 in Children With PFIC Clinical Trial page.